Literature DB >> 8009408

Tissue plasminogen activator thrombolysis and transluminal angioplasty in the treatment of basilar artery thrombosis: case report.

T Terada1, H Yokote, M Tsuura, Y Kinoshita, Y Hayashi, T Itakura, N Komai.   

Abstract

A 61-year-old man with basilar artery thrombotic occlusion was successfully treated by a combination of local infusion of tissue plasminogen activator (t-PA) followed by percutaneous transluminal angioplasty (PTA). t-PA superselective infusion combined with the mechanical destruction of the clot by the guide wire was effective for recanalization. A Stealth dilation catheter, with a 2.5-mm balloon diameter and 10-mm length, was used for PTA. A balloon inflation time of 60 seconds with 4 atmospheres of pressure was delivered for successful dilation of the basilar artery. It was confirmed to be widely patent on follow-up angiography 40 days after the combined procedure with no further ischemic attacks apparent on clinical examination at 6 months.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8009408     DOI: 10.1016/0090-3019(94)90026-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  3 in total

1.  Measurement of the intracranial arterial wedge pressure in cases of acute cerebral arterial occlusion to determine the indication of intraarterial thrombolytic therapy.

Authors:  T Terada; M Tsuura; H Matsumoto; O Masuo; G Hyotani; Y Ryujin; I Kamei; T Itakura
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

2.  Bleeding complications after basilar artery fibrinolysis with tissue plasminogen activator.

Authors:  D T Cross; C P Derdeyn; C J Moran
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

3.  Endovascular therapy for acute thrombotic occlusion of the intracranial artery.

Authors:  Tomoyuki Tsumoto; Tomoaki Terada; Mitsuharu Tsuura; Yukiaki Ryujin; Hiroyuki Matsumoto; Osamu Masuo; Hiroo Yamaga; Toru Itakura
Journal:  Neuroradiology       Date:  2004-05-13       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.